{{Rsnum
|rsid=6708316
|Gene=LPIN1
|Chromosome=2
|position=11797032
|Orientation=plus
|GMAF=0.3067
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
|Gene_s=LPIN1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 6.2 | 61.5 | 32.3
| HCB | 0.0 | 20.0 | 80.0
| JPT | 2.3 | 9.1 | 88.6
| YRI | 40.3 | 38.7 | 21.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 20.0 | 80.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20356931
|Title=Studies of association between LPIN1 variants and common metabolic phenotypes among 17,538 Danes
}}{{PMID|18591397|OA=1
}} Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. Populations.